This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Platelet-Derived Growth Factor Receptor Beta (PDGFRB)
Product Overview
BioVenic's Recombinant Equine Platelet-Derived Growth Factor Receptor Beta (PDGFRB) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 12.0 kDa. The purity is>95% (SDS-PAGE).
Specifications
Target Information
Equine platelet-derived growth factor receptor beta (PDGFRB) is a receptor tyrosine kinase that plays a significant role in cell proliferation, migration, and differentiation. In horses, PDGFRB is involved in tissue repair, angiogenesis, and the development of various tissues. It is also implicated in the progression of fibroproliferative diseases and may serve as a therapeutic target in conditions such as fibrosis and certain types of cancer.
Shipping and Storage
This product is shipped with dry ice. It is recommended to aliquote as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute at 100 μg/mL in 4 mM HCl.Aliquote the reconstituted solution to minimise freeze-thaw cycles.